| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/29/2004 | WO2004018472A3 Pyrimido compounds having antiproliferative activity |
| 04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/29/2004 | WO2003099823A3 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2002085909A8 9-deazaguanine derivatives as inhibitors of gsk-3 |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082785 Process for making an aldehyde |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040082781 Bicyclic nitrogenous fused-ring compound |
| 04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/29/2004 | US20040082647 Anticholesterol agents; controlling bile acid transfer into intestines |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082605 Use |
| 04/29/2004 | US20040082599 Compounds specific to adenosine A1 receptors and uses thereof |
| 04/29/2004 | US20040082598 Cardiovascular disorders; central nervous system disorders |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082583 Chemical compounds |
| 04/29/2004 | US20040082582 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/29/2004 | US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/29/2004 | US20040082574 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flavivridae infections |
| 04/29/2004 | US20040082573 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/29/2004 | US20040082572 Benzodiazepine derivatives as app modulators |
| 04/29/2004 | US20040082561 Antilipemic agents; anticholesterol agents |
| 04/29/2004 | DE19727828B4 Cyclohexan-1,2,4,5-diimid-Derivat und Verfahren zur Herstellung desselben Cyclohexane-1,2,4,5-diimide derivative and process for producing same |
| 04/29/2004 | CA2502644A1 Reverse-turn mimetics and composition and methods relating thereto |
| 04/29/2004 | CA2502515A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
| 04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | CA2501881A1 Pre-organized tricyclic integrase inhibitor compounds |
| 04/28/2004 | EP1413582A1 Dimeric pyrrolobenzodiazepines |
| 04/28/2004 | EP1413313A1 DIAGNOSIS AND TREATMENT OF INSULIN−DEPENDENT DIABETES MELLITUS AND INSULITIS |
| 04/28/2004 | EP1412364A1 Platelet adp receptor inhibitors |
| 04/28/2004 | EP1412360A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 04/28/2004 | EP1412359A1 Substituted 6-(2-tolyl)-triazolopyrimidines as fungicides |
| 04/28/2004 | EP1412358A1 6-(2,6-difluorophenyl)-triazolopyrimidines as fungicides |
| 04/28/2004 | EP1412357A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/28/2004 | EP1412356A1 Substituted 6-(2-methoxyphenyl)triazolopyrimidines as fungicides |
| 04/28/2004 | EP1412355A1 New pyrazolo(3,4-d)pyrimidines inhibiting h. pylori infections |
| 04/28/2004 | EP1412348A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres |
| 04/28/2004 | EP1412336A1 Peptoid compounds |
| 04/28/2004 | EP1412335A2 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/28/2004 | EP1411949A2 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/28/2004 | EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | EP1411927A1 Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
| 04/28/2004 | EP1227098B1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 04/28/2004 | EP1087970B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/28/2004 | EP1030646B1 Oxidation dyeing composition for keratinous fibres and dyeing method using same |
| 04/28/2004 | EP0922046B1 Process for the preparation of 7-alkoxyalkyl-1,2,4-triazolo 1,5-a] pyrimidine derivatives |
| 04/28/2004 | EP0782455B1 Use of porphyrins in the treatment of multiple sclerosis |
| 04/28/2004 | CN1491993A Optical recording medium containing substituted phthalonitrile compounds and its use |
| 04/28/2004 | CN1491944A 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation |
| 04/28/2004 | CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative |
| 04/28/2004 | CN1147546C Material having pigment coating on its substrate, and its use and digital-information reading method |
| 04/28/2004 | CN1147489C New bicyclo aminopyrazineone compound, its production process and medical composition containing them |
| 04/28/2004 | CN1147488C 6-(2-halo-4-alkoxyphenyl)-trizolopyrimidines, its preparation and use |
| 04/28/2004 | CN1147487C Racemization of R,S-dioxo-benzyl pyrrolopiperidine |
| 04/28/2004 | CN1147483C Adamantane derivatives |
| 04/27/2004 | US6727358 Nonlinear optical or electrical response |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders |
| 04/27/2004 | CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds |
| 04/22/2004 | WO2004033451A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives |
| 04/22/2004 | WO2004033444A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 04/22/2004 | WO2004033434A1 Pyrazole compounds for treatment of neurodegenerative disorders |
| 04/22/2004 | WO2004032845A2 R-nsaid esters and their use |
| 04/22/2004 | WO2004032836A2 Antidiabetic beta-amino heterocylcic dipeptidyl peptidase inhibitors |
| 04/22/2004 | WO2004009784A3 Novel inhibitors of kinases |
| 04/22/2004 | WO2004002986A3 Novel benzimidazole derivatives |
| 04/22/2004 | US20040077879 Building blocks linked together through the formation of rigid diketopiperazine rings |
| 04/22/2004 | US20040077874 Novel monomers and energy polymerizable compositions; use as waveguides in telecommunications industry |
| 04/22/2004 | US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector |
| 04/22/2004 | US20040077858 Making 4-(1H-indol-5-yloxy)-pyrrolo(2,1-f)(1,2,4)triazine compounds that are tyrosine kinase inhibitors; reducing vascular permeability; anticancer agents |
| 04/22/2004 | US20040077707 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 04/22/2004 | US20040077672 Anticarcinogenic, antiproliferative, and antitumor agents |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077667 Quinazolinone derivatives |
| 04/22/2004 | US20040077664 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 04/22/2004 | US20040077651 Fused N-heterocycle compounds as type-X sPLA2 (secretary PLA2) inhibitors; anticarcinogenic agents |
| 04/22/2004 | US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 04/22/2004 | US20040077625 Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake |
| 04/22/2004 | US20040077623 Antilepemic agents; low intestinal absorption; side effect reduction; modulating serum cholesterol concentration; preventing and treating arteriosclerotic conditions |
| 04/22/2004 | US20040077606 Anticancer, antiangiogenic agents; such as imidazo(1,5-a)-pyrazine-1,3-dione derivatives |
| 04/22/2004 | US20040077605 Cancer, immune disorders; such as 6-hydroxy-4-methyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-(trifluoromethyl)-benzonitrile |
| 04/22/2004 | US20040077554 Topoisomerase I inhibitors; such as 2,3-methylenedioxy-6-hydroxymethyl-9-hydroxy-12-(beta-D-glucopyranosyl) -6,7,12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione |
| 04/22/2004 | CA2501534A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 04/22/2004 | CA2501352A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives |
| 04/22/2004 | CA2501239A1 R-nsaid esters and their use |
| 04/22/2004 | CA2499586A1 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 04/21/2004 | EP1411057A1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 04/21/2004 | EP1409488A1 Imidazo-triazine derivatives as ligands for gaba receptors |
| 04/21/2004 | EP1409480A1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment |
| 04/21/2004 | EP1409468A2 Guanidinobenzamides as mc4-r agonists |
| 04/21/2004 | EP1409456A2 Detection of transmembrane potentials by optical methods |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1408970A1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
| 04/21/2004 | EP1408955A1 Novel metallotexaphyrin derivatives |
| 04/21/2004 | EP1109814B1 5-heterocyclyl pyrazolo 4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction |
| 04/21/2004 | EP1049699B1 Pyrazolotriazines as crf antagonists |